Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method

BACKGROUND: Precise prognostication is the key to optimum and effective treatment planning for early-stage hormone receptor (HR) positive, HER2/neu negative breast cancer patients. Differences in the breast cancer incidence and tumor anatomical features at diagnosis, pharmacogenomics data between We...

Descripción completa

Detalles Bibliográficos
Autores principales: Parikh, Purvish, Babu, Govind, Singh, Randeep, Krishna, Vamshi, Bhatt, Amit, Bansal, Indu, Rajappa, Senthil, Sahoo, Tarini Prasad, Aggarwal, Shyam, Bapna, Ajay, Biswas, Ghanshyam, Somashekhar, SP, Bajpai, Jyoti, Maniar, Vashishtha, Desai, Sharad, Raja, T, Rath, Goura Kishor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391857/
https://www.ncbi.nlm.nih.gov/pubmed/37525142
http://dx.doi.org/10.1186/s12885-023-11121-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391857/
https://www.ncbi.nlm.nih.gov/pubmed/37525142
http://dx.doi.org/10.1186/s12885-023-11121-9

Ejemplares similares